tiprankstipranks
Aileron Therapeutics Inc (ALRN)
NASDAQ:ALRN
Holding ALRN?
Track your performance easily

Aileron Therapeutics (ALRN) Financial Statements

1,198 Followers

Aileron Therapeutics Financial Overview

Aileron Therapeutics's market cap is currently ―. The company's EPS TTM is $-3.114; its P/E ratio is -0.79; Aileron Therapeutics is scheduled to report earnings on March 26, 2025, and the estimated EPS forecast is $-0.18. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -5.85M$ -8.94M$ -7.11M$ -7.30M$ -1.98M
EBITDA$ -5.85M$ -8.94M$ -7.05M$ -7.25M$ -1.97M
Net Income Common Stockholders$ -5.85M$ -8.94M$ -7.11M$ -7.34M$ -1.83M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 17.65M$ 21.92M$ 12.04M$ 17.31M$ 12.07M
Total Assets$ 104.22M$ 109.40M$ 99.19M$ 106.01M$ 12.82M
Total Debt$ 0.00$ 0.00$ 0.00$ 48.00K$ 0.00
Net Debt$ -17.65M$ -21.92M$ -12.04M$ -17.27M$ -12.07M
Total Liabilities$ 8.98M$ 8.38M$ 7.86M$ 7.71M$ 1.62M
Stockholders Equity$ 50.23M$ 56.02M$ 44.75M$ 6.89M$ 11.20M
Cash Flow-
Free Cash Flow$ -3.82M$ -8.39M$ -5.27M$ -10.39M$ -1.64M
Operating Cash Flow$ -3.82M$ -8.39M$ -5.27M$ -10.39M$ -1.64M
Investing Cash Flow---$ -96.00K$ 542.00K
Financing Cash Flow$ -446.00K$ 18.26M-$ 15.79M-
Currency in USD

Aileron Therapeutics Earnings and Revenue History

Aileron Therapeutics Debt to Assets

Aileron Therapeutics Cash Flow

Aileron Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis